COMMUNIQUÉS West-GlobeNewswire

5 Influential Companies In CBD-Infused Beverages

11/03/2019 - 14:00

VANCOUVER, British Columbia, March 11, 2019 (GLOBE NEWSWIRE) -- As consumer awareness around CBD continues to grow, cannabis companies are beginning to allocate an inordinate amount of investment capital into the [...]

Auxly Congratulates Streaming Partner Lotus Ventures on Obtaining Cannabis Licences From Health Canada

11/03/2019 - 14:00

VANCOUVER, British Columbia, March 11, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") today announced that its streaming partner, Lotus Ventures Inc. (“ Lotus ”), has [...]

Auris Medical Announces Publication of AM-111 Phase 3 Results in Peer-Reviewed Scientific Journal

11/03/2019 - 13:51

Zug, Switzerland, March 11, 2019 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous [...]

CORRECTION - Exactus Announces Agricultural Diversification with Entry Into 200 Acre Farming Project for 2019 Grow Season – Promotion of Emiliano Aloi as President

11/03/2019 - 13:50

“Exactus One World” Heralds Fully Diversified Strategy and Propels Exactus to Forefront of Rapidly Evolving CBD Industry GLEN ALLEN, Va., March 11, 2019 (GLOBE NEWSWIRE) -- This release corrects and replaces the version [...]

Precipio CEO Issues Shareholder Update Letter

11/03/2019 - 13:45

NEW HAVEN, Conn., March 11, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), issues the following letter from CEO Ilan Danieli. Dear Shareholders, Following our recent quarterly [...]

Share buy-back week 10/2019

11/03/2019 - 13:44

Announcement 11 March 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling [...]

Novo Nordisk A/S - Share repurchase programme

11/03/2019 - 13:34

Bagsværd, Denmark, 11 March 2019 - On 1 February 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]

Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University

11/03/2019 - 13:33

Groundbreaking GDF15 biomarker may be the first single examination to accurately predict disease progression NEW YORK, March 11, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc. ( QBIO ), a commercial stage biotechnology [...]

Progenics Pharmaceuticals Announces Presentation of Safety Data for AZEDRA® (iobenguane I 131) at the 2019 Endocrine Society (ENDO) Annual Meeting

11/03/2019 - 13:30

NEW YORK, March 11, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, today [...]

Caladrius Biosciences to Present at the Alliance for Regenerative Medicine 7th Annual Cell & Gene Therapy Investor Day

11/03/2019 - 13:30

BASKING RIDGE, N.J., March 11, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company committed to the [...]

Menlo Therapeutics to Present at the 31st Annual ROTH Conference

11/03/2019 - 13:30

REDWOOD CITY, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), [...]

Ultragenyx to Present at Upcoming Investor Conferences

11/03/2019 - 13:30

NOVATO, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]

Cocrystal Pharma Announces Closing of Private Placement

11/03/2019 - 13:30

BOTHELL, WA, March 11, 2019 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, [...]

First patient dosed in a Phase 2 study with LiPlaCis in prostate cancer

11/03/2019 - 13:11

Press release Hoersholm, Denmark and Cambridge, MA, US, March 11, 2019 – Oncology Venture A/S (“OV” or “the Company”) today announced that the first patient has been dosed in a Phase 2 study with LiPlaCis ® in prostate [...]

Merus to Present at the Cowen & Co. 39th Annual Health Care Conference

11/03/2019 - 13:09

UTRECHT, Netherlands, March 11, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human [...]

Catalyst Pharmaceuticals to Hold Fourth Quarter Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 19th, 2019

11/03/2019 - 13:03

CORAL GABLES, Fla., March 11, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]

Alfardan Medical with Northwestern Medicine select Allscripts

11/03/2019 - 13:01

Allscripts first client in Qatar to provide first-of-its-kind ambulatory care services CHICAGO, March 11, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) announced today that Alfardan Group , one of the leading [...]

Daré Bioscience receives notification of second award from the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development for the development of Ovaprene®

11/03/2019 - 13:00

SAN DIEGO, March 11, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that it received a second Notice of Award of $982,851, part of a grant providing [...]

Principia Biopharma Reacquires Rights to Oral Immunoproteasome Program

11/03/2019 - 13:00

-- Principia and AbbVie mutually agree to end collaboration -- -- Preclinical stage program focused on development of oral immunoproteasome inhibitors to treat inflammation and autoimmune disorders -- SOUTH SAN [...]